[A second allogeneic transplantation with a mild conditioning regimen in a patient with a posttransplantation relapse of lymphoblastic lymphoma after achieving aplasia with Daunoxome and alkeran].
Obukhova
E E
EE
Melkova
K N
KN
Tugova
S V
SV
Konchalovskiĭ
M V
MV
Baranov
A E
AE
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation / Q000379:methods*; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000008:administration & dosage*; D006801:Humans; D008081:Liposomes; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012008:Recurrence; D019233:Retreatment / Q000379:methods; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D008081:Liposomes; D008558:Melphalan; D003630:Daunorubicin